Literature DB >> 8583378

Ophthalmic preservatives as absorption promoters for ocular drug delivery.

H Sasaki1, T Nagano, K Yamamura, K Nishida, J Nakamura.   

Abstract

The effects of ophthalmic preservatives on the drug permeability through isolated ocular membranes of albino rabbits were investigated using a two-chamber glass diffusion cell. Tilisolol and fluorescein isothiocyanate (FITC)-dextrans (average molecular weights 4400 and 9400 Da; FD-4 and FD-10, respectively) were used as model penetrants of ophthalmic beta-blockers and peptide drugs. Preservatives significantly enhanced the corneal penetration of not only tilisolol but also FITC-dextrans. Especially, benzalkonium chloride increased the corneal permeability of FD-4 and FD-10 by 28.8 and 37.1 times, respectively. These results indicate the usefulness of ophthalmic preservatives as absorption promoters for the ocular delivery of beta-blockers and hydrophilic macromolecules. Preservatives also enhanced the conjunctival permeability of tilisolol, FD-4 and FD-10. The promoting effect of preservatives on the conjunctival drug penetration was smaller than that on the corneal one. Preservative increased the ratio of corneal to conjunctival permeability of tilisolol, FD-4 and FD-10. The different responses of corneal and conjunctival drug penetrations to ophthalmic preservatives may be useful to control the extent and pathway for the ocular and systemic absorptions of instilled drugs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8583378     DOI: 10.1111/j.2042-7158.1995.tb06726.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  8 in total

1.  Penetration of engineered antibody fragments into the eye.

Authors:  M A Thiel; D J Coster; S D Standfield; H M Brereton; C Mavrangelos; H Zola; S Taylor; A Yusim; K A Williams
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Corneal toxicity secondary to inadvertent use of benzalkonium chloride preserved viscoelastic material in cataract surgery.

Authors:  H Eleftheriadis; M Cheong; S Sandeman; P P Syam; P Brittain; G K Klintworth; A Lloyd; C Liu
Journal:  Br J Ophthalmol       Date:  2002-03       Impact factor: 4.638

3.  Ocular tolerance of absorption enhancers in ophthalmic preparations.

Authors:  Pascal Furrer; Joachim Michael Mayer; Bernard Plazonnet; Robert Gurny
Journal:  AAPS PharmSci       Date:  2002

4.  NC-1059: a channel-forming peptide that modulates drug delivery across in vitro corneal epithelium.

Authors:  Jesica Martin; Pradeep Malreddy; Takeo Iwamoto; Lisa C Freeman; Harriet J Davidson; John M Tomich; Bruce D Schultz
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

5.  Ocular pharmacokinetics of 0.45% ketorolac tromethamine.

Authors:  Mayssa Attar; Rhett Schiffman; Lisa Borbridge; Quinn Farnes; Devin Welty
Journal:  Clin Ophthalmol       Date:  2010-12-01

6.  Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.

Authors:  Ramesh Srirangam; Ketan Hippalgaonkar; Bharathi Avula; Ikhlas A Khan; Soumyajit Majumdar
Journal:  J Ocul Pharmacol Ther       Date:  2012-07-13       Impact factor: 2.671

7.  Short-Term Effect of Low-Dose Atropine and Hyperopic Defocus on Choroidal Thickness and Axial Length in Young Myopic Adults.

Authors:  Beata P Sander; Michael J Collins; Scott A Read
Journal:  J Ophthalmol       Date:  2019-08-21       Impact factor: 1.909

8.  Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs.

Authors:  Gen Suzuki; Eriko Kunikane; Keisuke Shinno; Seiko Kozai; Masaaki Kurata; Akio Kawamura
Journal:  Ophthalmol Ther       Date:  2020-01-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.